[Pt(
Antineoplastic Agents
/ chemical synthesis
Autophagy
/ drug effects
Carcinoma, Renal Cell
/ drug therapy
Cell Cycle
/ drug effects
Cell Proliferation
/ drug effects
Dose-Response Relationship, Drug
Drug Screening Assays, Antitumor
Humans
Organoplatinum Compounds
/ chemical synthesis
Structure-Activity Relationship
Tumor Cells, Cultured
apoptosis
autophagy
cancerous renal cells
cisplatin
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
06 03 2019
06 03 2019
Historique:
received:
24
01
2019
revised:
23
02
2019
accepted:
26
02
2019
entrez:
9
3
2019
pubmed:
9
3
2019
medline:
23
8
2019
Statut:
epublish
Résumé
We have demonstrated the cytotoxic effects of [Pt(
Identifiants
pubmed: 30845773
pii: biom9030092
doi: 10.3390/biom9030092
pmc: PMC6468382
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Organoplatinum Compounds
0
Pt(O,O'-acac)(gamma-acac)(DMS)
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Anticancer Res. 1999 Mar-Apr;19(2C):1541-3
pubmed: 10365141
J Urol. 2000 Feb;163(2):408-17
pubmed: 10647643
Endocr Rev. 2001 Apr;22(2):153-83
pubmed: 11294822
J Endocrinol. 2002 May;173(2):315-23
pubmed: 12010639
Oncogene. 2005 Feb 3;24(6):980-91
pubmed: 15592527
J Cell Mol Med. 2005 Jan-Mar;9(1):59-71
pubmed: 15784165
Cell. 2005 Sep 23;122(6):927-39
pubmed: 16179260
Kidney Int. 2006 Apr;69(7):1139-45
pubmed: 16609680
JAMA. 2006 Jun 7;295(21):2516-24
pubmed: 16757724
Autophagy. 2007 Jan-Feb;3(1):28-31
pubmed: 16969128
Biochem Pharmacol. 2007 Jun 30;74(1):28-40
pubmed: 17481588
Oncogene. 2007 Oct 25;26(49):7038-48
pubmed: 17486061
N Engl J Med. 2007 May 31;356(22):2271-81
pubmed: 17538086
Br J Pharmacol. 2008 Jan;153(1):34-49
pubmed: 18026127
Lancet. 2007 Dec 22;370(9605):2103-11
pubmed: 18156031
Autophagy. 2008 Oct;4(7):949-51
pubmed: 18769111
Oncogene. 2009 Feb 12;28(6):886-98
pubmed: 19060920
Biochem Biophys Res Commun. 2009 May 15;382(4):726-9
pubmed: 19318089
Dalton Trans. 2009 Oct 7;(37):7786-95
pubmed: 19759954
J Cell Biochem. 2010 Mar 1;109(4):764-73
pubmed: 20052671
Oncogene. 2010 Apr 8;29(14):2070-82
pubmed: 20101227
Autophagy. 2010 Nov;6(8):1066-77
pubmed: 20864811
Nat Cell Biol. 2011 Feb;13(2):132-41
pubmed: 21258367
Biochem Pharmacol. 2011 Jun 1;81(11):1271-85
pubmed: 21420390
Nat Rev Clin Oncol. 2011 May 17;8(9):528-39
pubmed: 21587219
J Transl Med. 2011 Aug 11;9:133
pubmed: 21834980
Lancet. 2011 Dec 3;378(9807):1931-9
pubmed: 22056247
Chin J Cancer. 2013 Mar;32(3):113-20
pubmed: 22835386
Mol Neurobiol. 2013 Jun;47(3):1000-10
pubmed: 23329343
PLoS One. 2013;8(1):e54918
pubmed: 23349989
J Cancer Res Clin Oncol. 2013 May;139(5):817-27
pubmed: 23397357
J Cell Physiol. 2013 Sep;228(9):1873-83
pubmed: 23460117
Eur J Cancer. 2013 Apr;49(6):1374-403
pubmed: 23485231
J Natl Cancer Inst. 1990 Jul 4;82(13):1107-12
pubmed: 2359136
Lancet Oncol. 2013 May;14(6):552-62
pubmed: 23598172
BMC Complement Altern Med. 2013 Sep 23;13:233
pubmed: 24053190
Cancer Lett. 2014 Mar 28;344(2):174-9
pubmed: 24333738
Int J Mol Sci. 2014 Feb 21;15(2):3145-53
pubmed: 24566140
Toxicol Lett. 2014 Aug 4;228(3):248-59
pubmed: 24875536
Mol Cancer. 2014 Jun 16;13:152
pubmed: 24935000
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Biochem Biophys Res Commun. 2016 Apr 22;473(1):47-53
pubmed: 26995091
Br J Pharmacol. 2016 Sep;173(17):2633-44
pubmed: 27351124
PLoS One. 2016 Nov 2;11(11):e0165154
pubmed: 27806086
PLoS One. 2017 Jul 12;12(7):e0181114
pubmed: 28704484
Toxicol Appl Pharmacol. 2019 Feb 1;364:1-11
pubmed: 30529627
Cancer Res. 1995 Feb 1;55(3):590-6
pubmed: 7834629